Elasomeran

艾拉索米瑞

Report date: 2026/05/12 09:09:22

Base Information

Drug NameElasomeran
Drug Alias NameModerna Covid-19 vaccineSARS-CoV-2 vaccine (Moderna Therapeutics/National Institute of Allergy and Infectious Diseases)mRNA-1273 SARS-CoV-2single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2COVID-19 Vaccine Moderna +[9] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationCoronavirus Disease 2019 (COVID-19)Solid tumours +[12] 
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2020/12/23
Country/TerritoryCanadaBotswanaZambia +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesModerna IncNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesGovernment Of CanadaModerna IncAdium Pharma SA +[12] 
Inactive CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979Leiden University Medical CenterUniversity Of California, Los Angeles +[4] 
Active IndicationsRejection of renal transplantationCoronavirus Disease 2019 (COVID-19)Solid tumours +[11] 
Inactive IndicationsInfections

Other Information

ATC CodeJ07
Related LinksN/A